(Q40249311)

2

1 reference

18 September 2017

Lee C Vermeulen

3

1 reference

18 September 2017

Penny Grim

5

1 reference

18 September 2017

Robert J Hunkler

6

1 reference

18 September 2017

Karrie M Hontz

American Journal of Health-System Pharmacy

7

1 reference

18 September 2017

1 February 2007

1 reference

18 September 2017

1 reference

18 September 2017

64

1 reference

18 September 2017

298-314

1 reference

18 September 2017

3

1 reference

18 September 2017

National health spending in 2004: recent slowdown led by prescription drug spending

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Health benefits in 2005: premium increases slow down, coverage continues to erode

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Health Spending Projections Through 2015: Changes On The Horizon

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

The effect of population aging on future hospital demand

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Projecting future drug expenditures--2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

"Me-too" products--friend or foe?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

The price of innovation: new estimates of drug development costs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Estimating the cost of new drug development: is it really 802 million dollars?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Are development times for pharmaceuticals increasing or decreasing?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Selective postoperative inhibition of gastrointestinal opioid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Alvimopan for the management of postoperative ileus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Outpatient gatifloxacin therapy and dysglycemia in older adults

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Echinocandins in the management of invasive fungal infections, part 1

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Micafungin: a new echinocandin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Ranibizumab for neovascular age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

The market for follow-on biologics: how will it evolve?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Medication counseling in Zimbabwe

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

The first months of the prescription-drug benefit--a CMS update

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

New economics of the pharmaceutical supply chain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Changing dynamics in the pharmaceutical supply chain: a GPO perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060545